NovoCure Limited (NVCR) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Novocure Limited.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:02.794 Time all participants on the listen-only mode. 00:00:02.794 -- 00:00:06.438 After the speaker's presentation, there will be a question and answer session. 00:00:06.438 -- 00:00:10.562 To ask a question during the session, you will need to press star 1-1 on your telephone. 00:00:10.562 -- 00:00:14.205 You will then hear an automated message advising your hand is raised. 00:00:14.205 -- 00:00:17.088 Please note that today's conference may be recorded. 00:00:17.088 -- 00:00:20.472 I will now hand the conference over to your speaker host, Ingrid Goldberg. 00:00:20.472 -- 00:00:22.912 Please go ahead. 00:00:23.515 -- 00:00:29.239 Good morning, and thank you for joining us to review Novocare's second quarter 2025 performance. 00:00:29.393 -- 00:00:33.817 I am on the phone this morning with our Executive Chairman, Bill Doyle, CEO, Ashley Cordova, 00:00:33.817 -- 00:00:38.082 and CFO, Christoph Brockman. Other members of our Executive Leadership Team will be available 00:00:38.082 -- 00:00:42.606 for Q&A. For your reference, slides accompanying this earnings release can be found on 00:00:42.606 -- 00:00:45.369 our website, www.novicure.com, 00:00:45.369 -- 00:00:48.212 on the Investor Relations page under Quarterly Reports. 00:00:48.212 -- 00:00:51.215 Before we start, I would like to remind you that our discussions during this conference 00:00:51.215 -- 00:00:55.059 call will include forward-looking statements, and actual results could differ materially 00:00:55.059 -- 00:00:58.742 from those projected in these statements. These statements involve a number of risks 00:00:58.742 -- 00:01:02.026 and uncertainties, some of which are beyond our control, and are described from time 00:01:02.026 -- 00:01:06.871 to time in our SEC filings. We do...